How is the Anti Microbial Peptides Market Poised for Growth: Trends and Opportunities Through 2034
Get 15% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!
How has the anti microbial peptides market grown over the years?
In recent times, there has been significant growth in the anti-microbial peptides market. From $6.49 billion in 2024, it is projected to increase to $7.03 billion in 2025, with a compound annual growth rate (CAGR) of 8.5%. The notable growth during the historical period can be related to the increasing incidence of antibiotic-resistant infections, the surging demand for new antimicrobial treatments, concerns regarding the effectiveness of conventional antibiotics, and the augmentation of research funding focusing on antimicrobial drug discovery.
What Is the forecasted market size and growth rate for the anti microbial peptides market?
The market for anti microbial peptides is projected to experience robust growth in the coming years, with its value estimated to reach $9.63 billion in 2029, increasing at a compound annual growth rate of 8.2%. The escalation during the forecast period is expected due to factors such as heightened demand in the healthcare sector, regulatory verifications, increased funding in peptide-based drug innovation, a stronger emphasis on countering antimicrobial resistance, and progress in peptide synthesis and delivery technology. Key trends in the projected period encompass technological evolution, creative therapeutics, biotechnology methods, research and development, formulation of engineered peptides, and progress in the field of biotechnology.
Get your anti microbial peptides market report here!
https://www.thebusinessresearchcompany.com/report/anti-microbial-peptides-global-market-report
What are the major factors driving growth in the anti microbial peptides market?
The surge in infections is projected to boost the growth of the antimicrobial peptide market. These infections encompass conditions induced by damaging organisms like bacteria, viruses, fungi, or parasites. The surge can be linked to triggers like climate shifts, the emergence of drug-resistant pathogens, and unhealthy eating patterns. Antimicrobial peptides give a promising answer to dealing with infectious diseases by introducing new therapy options that tackle the mounting issue of antibiotic resistance and the restrictions of standard treatments. As an example, as per Gov.UK, a UK-based public sector information website, in England in October 2023, the number of new HIV diagnoses in 2022 was 3,805, indicating a 22% rise from the 3,118 cases in 2021. As such, the augmented incidence of infections is fueling the antimicrobial peptide market.
What key areas define the segmentation of the global anti microbial peptides Market?
The anti microbial peptides market covered in this report is segmented –
1) By Type: Plant Antimicrobial Peptides, Bacterial Antimicrobial Peptides, Animal Antimicrobial Peptides, Insect Antimicrobial Peptides
2) By Ailments: Pneumonia, Hepatitis, Bacterial infections, Human Immunodeficiency Viruses
3) By Route of Administration: Topical, Subcutaneous, Intravenous
4) By Distribution Channel: Hospital, Research Institutes, Specialty Clinic, Pharmacies
5) By End-User: Pharma And Healthcare, Agriculture Industry, Biological Engineering
Subsegments:
1) By Plant Antimicrobial Peptides: Defensins, Thionins, Hevein-Like Peptides, Plant Defensin-Like Peptides, Lipid Transfer Proteins (LTPs)
2) By Bacterial Antimicrobial Peptides: Bacitracin, Nisin, Magainins, Protegrins, Bacillocins
3) By Animal Antimicrobial Peptides: Cathelicidins, Defensins, Histatins, Lactoferrin, Cationic Antimicrobial Peptides (CAMPs)
4) By Insect Antimicrobial Peptides: Cecropins, Defensins, Attacins, Diptericins, Melittin
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20465&type=smp
What are the top market players propelling the growth of the anti microbial peptides industry?
Major companies operating in the anti-microbial peptides market are Wuxi AppTec, Sigma Aldrich Chemicals Private Limited, Ipsen S.A., Novozymes A/S, GenScript Biotech, Bachem Holding AG, Basilea Pharmaceutica Ltd., Probiotec Limited, Migenix Inc., Zymeworks Inc., Venatorx Pharmaceuticals Inc., AMPS Biotech Pvt. Ltd., AnaSpec Inc., MediGene AG, Hycult Biotech, Phoenix Biotechnology Inc., Shenzhen Sunsmile Biotechnology Co. Ltd., WatsonBio Sciences, Helix BioMedix, Jiangsu ProteLight Pharmaceutical and Biotechnology Co Ltd.
What are the key trends shaping the future of the anti microbial peptides market?
Leading firms in the anti-microbial peptides market are focusing on the creation of unique products like biodegradable antimicrobial peptides to tackle the rising issue of antimicrobial resistance and boost treatment effectiveness. These biodegradable antimicrobial peptides are short proteins that decompose naturally into non-harmful byproducts post-fulfilling their role of eliminating or inhibiting damaging microorganisms such as bacteria, viruses, and fungi. As an example, Beiersdorf AG, a personal care products manufacturer based in Germany, joined hands with Macro Biologics, a US bioengineering firm, to manufacture antimicrobial peptides in September 2024. This partnership is centred on devising innovative approaches using biodegradable antimicrobial peptides, illustrating a burgeoning trend in the cosmetics sector to incorporate avant-garde biotechnological inventions to meet both performance and sustainability goals.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20465
What regions are dominating the anti microbial peptides market growth?
North America was the largest region in the anti-microbial Peptides market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-microbial peptides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Biosimilar Therapeutic Peptides Global Market Report 2025
Oral Proteins And Peptides Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/oral-proteins-and-peptides-global-market-report
Bacterial And Plasmid Vectors Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/bacterial-and-plasmid-vector-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
